Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Sleep Medicine Topic Center

Conference Coverage
Link Between Poor Sleep and Poor Nutrition Is Significant
06/10/2019
In a study presented at Nutrition 2019, researchers used data from the National Health and Nutrition Evaluation Survey to investigate the relationship between poor sleep and the intake of micronutrients and macronutrients.
In a study presented at Nutrition 2019, researchers used data from the National Health and Nutrition Evaluation Survey to investigate the relationship between poor sleep and the intake of micronutrients and macronutrients.
In a study presented at...
06/10/2019
Neurology
News
5 Questions About OSA Diagnosis and Treatment
05/17/2019
Nancy Foldvary-Schaefer, DO, MS, from Cleveland Clinic, recently spoke about sleep disordered breathing in neurology populations at the American Academy of Neurology’s 2019 Annual Meeting. Here are her answers to our burning questions.
Nancy Foldvary-Schaefer, DO, MS, from Cleveland Clinic, recently spoke about sleep disordered breathing in neurology populations at the American Academy of Neurology’s 2019 Annual Meeting. Here are her answers to our burning questions.
Nancy Foldvary-Schaefer, DO, MS,...
05/17/2019
Neurology
Podcasts
David F. Dinges, MS, MA, PhD, on the Cognitive Effect of Sleep Medications After Emergent Awakenings
05/14/2019
In this podcast, David F. Dinges, MS, MA, PhD, talks about his latest research on the cognitive effects of 2 well-known and widely used sleep medications after emergent awakenings. This research was performed in NASA astronauts and personnel.
In this podcast, David F. Dinges, MS, MA, PhD, talks about his latest research on the cognitive effects of 2 well-known and widely used sleep medications after emergent awakenings. This research was performed in NASA astronauts and personnel.
In this podcast, David F....
05/14/2019
Neurology
Podcasts
Joseph A. Diamond, MD, on Continuous Management of Sleep Disorders
04/22/2019
Joseph Diamond, MD, from the Icahn School of Medicine, answers the question at the end of Case Part 4 and discusses the management and treatment of sleep disorders and drug-drug interactions between other simultaneous medication use.
Joseph Diamond, MD, from the Icahn School of Medicine, answers the question at the end of Case Part 4 and discusses the management and treatment of sleep disorders and drug-drug interactions between other simultaneous medication use.
Joseph Diamond, MD, from the...
04/22/2019
Neurology
Case Report and Brief Review
Understanding Sleep Disorders: Part 4
04/15/2019
Welcome to Part 4 of our series on sleep disorders with Joseph A. Diamond, MD, from the Icahn School of Medicine at Mount Sinai. Read this case, and send us your feedback. Then listen to next week's podcast for the answer!
Welcome to Part 4 of our series on sleep disorders with Joseph A. Diamond, MD, from the Icahn School of Medicine at Mount Sinai. Read this case, and send us your feedback. Then listen to next week's podcast for the answer!
Welcome to Part 4 of our series...
04/15/2019
Neurology
News
8 Questions About Hypersomnia Management
04/12/2019
Lynn Marie Trotti, MD, MSc, from Emory University, answers our questions about diagnosing, managing, and treating hypersomnia, even in patients who are refractory to first- and second-line therapies.
Lynn Marie Trotti, MD, MSc, from Emory University, answers our questions about diagnosing, managing, and treating hypersomnia, even in patients who are refractory to first- and second-line therapies.
Lynn Marie Trotti, MD, MSc, from...
04/12/2019
Neurology
Podcasts
Joseph A. Diamond, MD, on At-Home vs In-Lab Polysomnography for Sleep Disordered Breathing
04/08/2019
Joseph Diamond, MD, from the Icahn School of Medicine, answers the question at the end of Case Part 3 and discusses the difference between at-home vs in-lab polysomnography testing for sleep disordered breathing.
Joseph Diamond, MD, from the Icahn School of Medicine, answers the question at the end of Case Part 3 and discusses the difference between at-home vs in-lab polysomnography testing for sleep disordered breathing.
Joseph Diamond, MD, from the...
04/08/2019
Neurology
News
Understanding Sleep Disorders: Part 3
04/01/2019
Welcome to Part 3 of our series on sleep disorders with Dr Joseph A. Diamond from the Icahn School of Medicine at Mount Sinai. Read this case, and send us your feedback. Then listen to next week's podcast for the answer!
Welcome to Part 3 of our series on sleep disorders with Dr Joseph A. Diamond from the Icahn School of Medicine at Mount Sinai. Read this case, and send us your feedback. Then listen to next week's podcast for the answer!
Welcome to Part 3 of our series...
04/01/2019
Neurology
Podcasts
Joseph A. Diamond, MD, on Starting the Conversation About Sleep Disordered Breathing
03/25/2019
Joseph Diamond, MD, from the Icahn School of Medicine, answers the question at the end of Case Part 2 and explains how to start the conversation with your patients about sleep disordered breathing.
Joseph Diamond, MD, from the Icahn School of Medicine, answers the question at the end of Case Part 2 and explains how to start the conversation with your patients about sleep disordered breathing.
Joseph Diamond, MD, from the...
03/25/2019
Neurology
Poll
Poll: Diagnosing Sleep Disorders
03/20/2019
We want to know which expert you think should be diagnosing sleep disorders. Share your opinion by taking our poll.
We want to know which expert you think should be diagnosing sleep disorders. Share your opinion by taking our poll.
We want to know which expert you...
03/20/2019
Neurology

Advertisement

Advertisement

News

Pitolisant Receives FDA Approval for Pediatric Patients With Narcolepsy
News
Pitolisant Receives FDA Approval for Pediatric Patients With Narcolepsy
07/23/2024
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug...
07/23/2024
Neurology
Young woman sleeping
News
Adolescents With Higher Adiposity More Vulnerable to Cognitive Impairments From Poor Sleep
06/13/2024
Meagan Thistle
Adolescents with higher levels of adiposity may be more susceptible to the cognitive effects of sleep restriction than those with lower adiposity, according to a recent single-blind randomized crossover trial.
Adolescents with higher levels of adiposity may be more susceptible to the cognitive effects of sleep restriction than those with lower adiposity, according to a recent single-blind randomized crossover trial.
Adolescents with higher levels...
06/13/2024
Neurology
A man sleeps
News
Computational Model of Respiratory Tract Dispels Concerns Over CPAP Safety
05/28/2024
Jolynn Tumolo
Continuous positive airway pressure (CPAP) therapy is safe and effective in patients with obstructive sleep apnea (OSA) syndrome, according to study findings published in the journal Respiratory Physiology & Neurobiology.
Continuous positive airway pressure (CPAP) therapy is safe and effective in patients with obstructive sleep apnea (OSA) syndrome, according to study findings published in the journal Respiratory Physiology & Neurobiology.
Continuous positive airway...
05/28/2024
Neurology
Sleep apnea during REM cycle
News
Obstructive Sleep Apnea Events During REM Sleep Impacts Verbal Memory in Those at Risk for AD
05/20/2024
Jolynn Tumolo
The severity of obstructive sleep apnea (OSA) events during REM sleep is associated with worse verbal memory impairment in older adults at risk for Alzheimer disease (AD), according to a study published online in the journal Alzheimer’s...
The severity of obstructive sleep apnea (OSA) events during REM sleep is associated with worse verbal memory impairment in older adults at risk for Alzheimer disease (AD), according to a study published online in the journal Alzheimer’s...
The severity of obstructive...
05/20/2024
Neurology
Sleep Disorders Linked With Epilepsy in Older Adults
News
Sleep Disorders Linked With Epilepsy in Older Adults
05/07/2024
Jolynn Tumolo
Sleep apnea and low oxygen levels during sleep are associated with late-onset epilepsy independently of hypertension and stroke, according to a study published online in the journal Sleep.
Sleep apnea and low oxygen levels during sleep are associated with late-onset epilepsy independently of hypertension and stroke, according to a study published online in the journal Sleep.
Sleep apnea and low oxygen...
05/07/2024
Neurology
A man lies in bed awake due to insomnia
News
Insomnia Symptoms May Prompt More Drinking Over Time
04/18/2024
Brionna Mendoza
Insomnia symptoms, even if mild, were found to be associated with increased drinking over time, according to findings from the “first study to examine if objective circadian measures can predict future alcohol use in adults.”
Insomnia symptoms, even if mild, were found to be associated with increased drinking over time, according to findings from the “first study to examine if objective circadian measures can predict future alcohol use in adults.”
Insomnia symptoms, even if mild,...
04/18/2024
Psych Congress Network
a doctor holds a generic orange pill bottle
News
Zenzedi CII 30 mg Tablets Recalled Over Mislabeling Concerns
01/29/2024
Meagan Thistle
zurity Pharmaceuticals, Inc. has issued a voluntary recall of 1 lot of Zenzedi CII 30 mg tablets after a Nebraska pharmacist discovered carbinoxamine maleate, an antihistamine, in a bottle labeled as Zenzedi 30 mg.
zurity Pharmaceuticals, Inc. has issued a voluntary recall of 1 lot of Zenzedi CII 30 mg tablets after a Nebraska pharmacist discovered carbinoxamine maleate, an antihistamine, in a bottle labeled as Zenzedi 30 mg.
zurity Pharmaceuticals, Inc. has...
01/29/2024
Neurology
a woman struggles to sleep
News
Genetic Predisposition for Short Sleep Linked With Future Depression Onset
12/05/2023
Jolynn Tumolo
A genetic predisposition to sleeping fewer than 5 hours a night was strongly associated with depression onset over an average 8 years of follow-up in adults 50 years and older, according to a study published in Translational Psychiatry.
A genetic predisposition to sleeping fewer than 5 hours a night was strongly associated with depression onset over an average 8 years of follow-up in adults 50 years and older, according to a study published in Translational Psychiatry.
A genetic predisposition to...
12/05/2023
Neurology
A little girl sleeps with her mouth hanging open
News
Regular Snoozers Appear to Benefit From Putting Off Morning Rise
11/08/2023
Jolynn Tumolo
Hitting the snooze button for 30 minutes in the morning slightly improved or did not affect cognitive performance upon waking in habitual snoozers, according to research published in the Journal of Sleep Research.
Hitting the snooze button for 30 minutes in the morning slightly improved or did not affect cognitive performance upon waking in habitual snoozers, according to research published in the Journal of Sleep Research.
Hitting the snooze button for 30...
11/08/2023
Neurology
Overhead view of a Black man asleep in bed wearing a CPAP device
News
For Some Sleep Apnea Patients, Noninvasive Electrical Stimulation May Improve Symptoms
08/21/2023
Jolynn Tumolo
Just 3 months of home-based transcutaneous electrical stimulation improved obstructive sleep apnea (OSA) severity and sleepiness in patients with low adherence to continuous positive airway pressure (CPAP) therapy.
Just 3 months of home-based transcutaneous electrical stimulation improved obstructive sleep apnea (OSA) severity and sleepiness in patients with low adherence to continuous positive airway pressure (CPAP) therapy.
Just 3 months of home-based...
08/21/2023
Neurology
Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial
News
Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial
08/08/2024
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive...
08/08/2024
Neurology
brain waves
News
High-Dose Statins May Not Benefit Patients With Mild Ischemic Stroke
08/08/2024
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose...
08/08/2024
Neurology
An illustration of a healthcare provider conducting a telehealth appointment
News
Teleneurology Visits Acceptable to Patients Across Neurologic Conditions
08/05/2024
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic...
08/05/2024
Neurology
The US Food and Drug Administration headquarters sign.
News
DMD Gene Therapy Indication Expanded to Include Boys 4 and Older
08/01/2024
The US FDA approved an indication expansion for the gene therapy Elevidys (delandistrogene moxeparvovec-rokl) to include patients with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are nonambulatory and 4...
The US FDA approved an indication expansion for the gene therapy Elevidys (delandistrogene moxeparvovec-rokl) to include patients with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are nonambulatory and 4...
The US FDA approved an...
08/01/2024
Neurology
A person walks down a boarded path with sunlight and trees in the background
News
Backward Walking Speed Reserve Reflects Disease Severity in Patients With MS
07/30/2024
Backward walking speed reserve, or the difference between an individual’s preferred and maximal backward walking speed, was associated with disease severity in patients with multiple sclerosis (MS).
Backward walking speed reserve, or the difference between an individual’s preferred and maximal backward walking speed, was associated with disease severity in patients with multiple sclerosis (MS).
Backward walking speed reserve,...
07/30/2024
Neurology
FDA Approves Efgartigimod Alfa/Hyaluronidase for CIDP Treatment
News
FDA Approves Efgartigimod Alfa/Hyaluronidase for CIDP Treatment
07/29/2024
VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). 
VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). 
VYVGART Hytrulo (efgartigimod...
07/29/2024
Neurology
A middle-aged male running
News
Moderate Physical Activity May Mitigate ALS Risk for Male Patients
07/25/2024
Male individuals who engage in moderate physical activity and fitness may lower their risk for amyotrophic lateral sclerosis (ALS) later in life, according to study findings published in Neurology.
Male individuals who engage in moderate physical activity and fitness may lower their risk for amyotrophic lateral sclerosis (ALS) later in life, according to study findings published in Neurology.
Male individuals who engage in...
07/25/2024
Neurology
Pitolisant Receives FDA Approval for Pediatric Patients With Narcolepsy
News
Pitolisant Receives FDA Approval for Pediatric Patients With Narcolepsy
07/23/2024
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug...
07/23/2024
Neurology
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
News
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
07/22/2024
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was...
07/22/2024
Neurology
a hand breaks a wooden human figurine in half
News
Atogepant Reduces Migraine Days in Patients With Pain Medication Overuse
07/18/2024
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related...
07/18/2024
Neurology

Advertisement

Advertisement

Alzheimer's Disease CME Series

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/12/2020
Neurology
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology
11/12/2020
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease...
11/12/2020
Neurology
Claim-Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early...
11/12/2020
Neurology
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
11/10/2020
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations...
11/10/2020
Neurology

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement